Search - tctmd.com

Displaying 141 - 160 of 722

Sort: Relevancy | Date

Two New Renal Denervation Systems Look Good in Uncontrolled BP

News Conference News EuroPCR 2023

Two New Renal Denervation Systems Look Good in Uncontrolled BP

May 17, 2023

May 2023 News Roundup

News Opinion CV Team Dispatch

May 2023 News Roundup

May 01, 2023

The Promise of AI for Improving Health Equity in Heart Failure

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

April 04, 2023

The Evolving Role of Industry and the Interventional Cardiology Fellow

News Opinion Fellow Talk

The Evolving Role of Industry and the Interventional Cardiology Fellow

Poornima Mohan, MBChB

March 31, 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

March 22, 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

News Conference News ACC 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

March 08, 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

News Conference News CRT 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Yael L. Maxwell

February 28, 2023

European Societies Define Best Practices for Performing Renal Denervation

News Daily News

European Societies Define Best Practices for Performing Renal Denervation

February 21, 2023

What’s New In Renal Denervation?

Presentation Miami Valves 2023

What’s New In Renal Denervation?

Presenter: Sergio Perez

February 04, 2023

The Spyral HTN-ON MED Pilot Study

Podcast TCTMD Talking Points

The Spyral HTN-ON MED Pilot Study

February 01, 2023

BP Reduction With Renal Denervation Still Evident a Decade On

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

TCTMD’s Top 10 Most Popular Stories for December 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

January 03, 2023

Reduction in BP Drives Treatment Preference for Hypertensive Patients

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Presentation AHA 2022

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Presenter: David E. Kandzari

November 07, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

TCTMD’s Top 10 Most Popular Stories for September 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

October 03, 2022

Discussion - What does this Field Need Next?

Presentation TCT 2022

Discussion - What does this Field Need Next?

Presenter: Felix Mahfoud

September 19, 2022

Who Should be Treated with uRDN?

Presentation TCT 2022

Who Should be Treated with uRDN?

Presenter: Naomi Fisher

September 19, 2022

Discussion - Key Takeaways from the RADIANCE Clinical Program

Presentation TCT 2022

Discussion - Key Takeaways from the RADIANCE Clinical Program

Presenter: Felix Mahfoud

September 19, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.